BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32561028)

  • 1. Risk factors for hemolytic transfusion reactions resulting from ABO and minor red cell antigen incompatibility: From mislabeled samples to stem cell transplant and sickle cell disease.
    Gehrie EA; Savani BN; Booth GS
    Blood Rev; 2021 Jan; 45():100719. PubMed ID: 32561028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B; Padmanabhan S; Paley C; Chandrasekaran V
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
    Josephson CD; Castillejo MI; Grima K; Hillyer CD
    Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.
    Chonat S; Arthur CM; Zerra PE; Maier CL; Jajosky RP; Yee MEM; Miller MJ; Josephson CD; Roback JD; Fasano R; Stowell SR
    Transfus Clin Biol; 2019 May; 26(2):130-134. PubMed ID: 30979566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cause and pathogenesis of hemolytic transfusion reactions in sickle-cell disease.
    Pirenne F
    Curr Opin Hematol; 2019 Nov; 26(6):488-494. PubMed ID: 31589171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation.
    Yazer MH; Triulzi DJ
    Curr Opin Hematol; 2007 Nov; 14(6):664-70. PubMed ID: 17898572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemolysis from ABO Incompatibility.
    Simmons DP; Savage WJ
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):429-43. PubMed ID: 26043383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immuno-hematological findings in Delayed Hemolytic Transfusion Reaction (DHTR).
    Thonier V
    Transfus Clin Biol; 2019 May; 26(2):102-108. PubMed ID: 30885514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
    Fasano RM; Miller MJ; Chonat S; Stowell SR
    Transfus Clin Biol; 2019 May; 26(2):94-98. PubMed ID: 30837199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When O Bites Back: Unrecognized Acute Hemolytic Reaction from Out-of-Group HLA-Compatible Platelet Transfusion.
    Pasion JO; Song LH; McCusker MG; Shimer L; Bryant A; McGann HL; Fontaine MJ
    Ann Clin Lab Sci; 2021 Mar; 51(2):267-270. PubMed ID: 33941569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed hemolytic transfusion reaction in children with sickle cell disease.
    de Montalembert M; Dumont MD; Heilbronner C; Brousse V; Charrara O; Pellegrino B; Piguet C; Soussan V; Noizat-Pirenne F
    Haematologica; 2011 Jun; 96(6):801-7. PubMed ID: 21330322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease.
    Gerritsma J; Bongaerts V; Eckhardt C; Heijboer H; Nur E; Biemond B; van der Schoot E; Fijnvandraat K;
    Br J Haematol; 2022 Feb; 196(3):769-776. PubMed ID: 34632580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed hemolytic transfusion reaction in sickle cell disease.
    Scheunemann LP; Ataga KI
    Am J Med Sci; 2010 Mar; 339(3):266-9. PubMed ID: 20051821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe hemolytic transfusion reaction due to anti-A1 following allogeneic stem cell transplantation with minor ABO incompatibility.
    Akkök CA; Haugaa H; Galgerud A; Brinch L
    Transfus Apher Sci; 2013 Feb; 48(1):63-6. PubMed ID: 22902604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red blood cell transfusion in patients with anti-Yt
    Wong SM; Cawthorne T; Dennington PM; Hong FS
    Transfusion; 2021 Feb; 61(2):379-384. PubMed ID: 33410173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of blood groups in transfusion of sickle cell disease patients.
    Noizat-Pirenne F
    C R Biol; 2013 Mar; 336(3):152-8. PubMed ID: 23643398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatal acute hemolytic transfusion reaction due to anti-B from a platelet apheresis unit stored in platelet additive solution.
    Balbuena-Merle R; West FB; Tormey CA; Hendrickson JE
    Transfusion; 2019 Jun; 59(6):1911-1915. PubMed ID: 30865314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Balbuena-Merle R; Hendrickson JE
    Transfus Clin Biol; 2019 May; 26(2):112-115. PubMed ID: 30857806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.